These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11987814)

  • 1. LCMV and the central nervous system: uncovering basic principles of CNS physiology and virus-induced disease.
    Evans CF; Redwine JM; Patterson CE; Askovic S; Rall GF
    Curr Top Microbiol Immunol; 2002; 263():177-95. PubMed ID: 11987814
    [No Abstract]   [Full Text] [Related]  

  • 2. Lymphocytic choriomeningitis infection of the central nervous system.
    Kang SS; McGavern DB
    Front Biosci; 2008 May; 13():4529-43. PubMed ID: 18508527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocytic choriomeningitis virus: invisible but not innocent.
    Lapošová K; Pastoreková S; Tomášková J
    Acta Virol; 2013; 57(2):160-70. PubMed ID: 23600874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biology and pathogenesis of lymphocytic choriomeningitis virus infection.
    Oldstone MB
    Curr Top Microbiol Immunol; 2002; 263():83-117. PubMed ID: 11987822
    [No Abstract]   [Full Text] [Related]  

  • 5. Contribution of LCMV towards deciphering biology of quasispecies in vivo.
    Sevilla N; Domingo E; de la Torre JC
    Curr Top Microbiol Immunol; 2002; 263():197-220. PubMed ID: 11987815
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemokines and the inflammatory response to viral infection in the central nervous system with a focus on lymphocytic choriomeningitis virus.
    Asensio VC; Kincaid C; Campbell IL
    J Neurovirol; 1999 Feb; 5(1):65-75. PubMed ID: 10190692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trace-forward investigation of mice in response to lymphocytic choriomeningitis virus outbreak.
    Edison L; Knust B; Petersen B; Gabel J; Manning C; Drenzek C; Ströher U; Rollin PE; Thoroughman D; Nichol ST;
    Emerg Infect Dis; 2014 Feb; 20(2):291-5. PubMed ID: 24447898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cells in the central nervous system: the delicate balance between viral clearance and disease.
    McGavern DB; Homann D; Oldstone MB
    J Infect Dis; 2002 Dec; 186 Suppl 2(Suppl 2):S145-51. PubMed ID: 12424690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system.
    von Herrath MG; Evans CF; Horwitz MS; Oldstone MB
    Immunol Rev; 1996 Aug; 152():111-43. PubMed ID: 8930670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral infection of transgenic mice expressing a viral protein in oligodendrocytes leads to chronic central nervous system autoimmune disease.
    Evans CF; Horwitz MS; Hobbs MV; Oldstone MB
    J Exp Med; 1996 Dec; 184(6):2371-84. PubMed ID: 8976191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus.
    Zahn RC; Schelp I; Utermöhlen O; von Laer D
    J Virol; 2007 Jan; 81(2):457-64. PubMed ID: 17020943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residues K465 and G467 within the Cytoplasmic Domain of GP2 Play a Critical Role in the Persistence of Lymphocytic Choriomeningitis Virus in Mice.
    Iwasaki M; Ng CT; Cubitt B; de la Torre JC
    J Virol; 2016 Nov; 90(22):10102-10112. PubMed ID: 27581982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytic choriomeningitis virus: ways to establish and maintain non-cytolytic persistent infection.
    Labudová M; Pastorek J; Pastoreková S
    Acta Virol; 2016 Mar; 60(1):15-26. PubMed ID: 26982463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perforin-deficient CD8+ T cells mediate fatal lymphocytic choriomeningitis despite impaired cytokine production.
    Storm P; Bartholdy C; Sørensen MR; Christensen JP; Thomsen AR
    J Virol; 2006 Feb; 80(3):1222-30. PubMed ID: 16414999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of humoral immunity explored through studies of LCMV infection.
    Slifka MK
    Curr Top Microbiol Immunol; 2002; 263():67-81. PubMed ID: 11987820
    [No Abstract]   [Full Text] [Related]  

  • 17. Diseases of the central nervous system caused by lymphocytic choriomeningitis virus and other arenaviruses.
    Wilson MR; Peters CJ
    Handb Clin Neurol; 2014; 123():671-81. PubMed ID: 25015511
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo selection of neutralization-resistant virus variants but no evidence of B cell tolerance in lymphocytic choriomeningitis virus carrier mice expressing a transgenic virus-neutralizing antibody.
    Seiler P; Senn BM; Bründler MA; Zinkernagel RM; Hengartner H; Kalinke U
    J Immunol; 1999 Apr; 162(8):4536-41. PubMed ID: 10201992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models using lymphocytic choriomeningitis virus.
    von Herrath M; Whitton JL
    Curr Protoc Immunol; 2001 May; Chapter 19():Unit 19.10. PubMed ID: 18432751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation on the mind: visualizing immunity in the central nervous system.
    Kang SS; McGavern DB
    Curr Top Microbiol Immunol; 2009; 334():227-63. PubMed ID: 19521688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.